Dr William Pao

William Pao

Personal Data

Nationality: American
Year of Birth: 1967


Head of Pharma Research & Early Development (pRED)


  • Harvard College, Cambridge, MA, US
    B.A. (1986-1990)
  • Yale University, Department of Biology, New Haven, CT, US
    M.D., Ph.D. (1990-1998)
  • New York-Presbyterian Hospital, Weill-Cornell Medical School Campus, New York, NY, US
    Department of Internal Medicine
    Intern and Junior Assistant Resident Internal Medicine (1998-2000)
  • Memorial Sloan-Kettering Cancer Center, New York, NY, US
    Fellow, Medical Oncology (2000-2004)
    Postdoctoral Fellow, Program in Cancer Biology & Genetics (2001-2005) 

Professional Career

  • Memorial Sloan-Kettering Cancer Center, New York, NY, US
    2004-2005 Assistant Member, MSKCC
    2004-2009 Assistant Attending Physician, Memorial Hospital for Cancer & Allied Diseases, Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine
    2005-2009 Assistant Member, Human Oncology & Pathogenesis Program
    2005-2009 Assistant Professor, Gerstner Sloan-Kettering Graduate School
    2006-2009 Miner Family Chair in Intrathoracic Cancers
  • Joan and Sanford I Weill-Cornell Graduate School of Medical Science, New York, NY, US
    2005-2006 Instructor in Medicine
    2006-2009 Assistant Professor of Medicine
    2006-2009 Assistant Professor, Biochemistry & Structural Biology, Cell Biology & Genetics, and Molecular Biology Allied Graduate Program
    2009-2011 Adjunct Assistant Professor, Program in Cell and Development Biology
  • Vanderbilt University, Nashville, TN, US
    2009-2012 Ingram Associate Professor of Medicine, Div of Haematology/Oncology
    2009 Assistant Director, Personalised Cancer Medicine
    2010 Director, Personalised Cancer Medicine
    2011-2014 Director, Div of Haematology/Oncology, Vanderbilt-Ingram Cancer Center
    2012-2014 Professor, Depts of Medicine, Cancer Biology and Pathology/Microbiology/Immunology 
    2012-2014 Cornelius Abernathy Craig Chair in Medical and Surgical Oncology 
    2014-present Adjunct Professor of Medicine, Division of Haematology/Oncology
  • F. Hoffmann-La Roche Ltd, Basel, Switzerland
    2014-2018 Global Head Oncology Discovery and Translational Area, Pharma Research and Early Development
    2018-present  Head of Roche Pharma Research & Early Development (pRED)

Awards and Honors (selected)

  • 1997
    John S Nicholas Prize for the outstanding doctoral candidate in “experimental zoology” (Biology Department), Yale University
  • 1998
    Elected to Alpha Omega Alpha
  • 2002
    Young Investigator Award, American Society of Clinical Oncology
  • 2004
    The CHEST Foundation and The LUNGevity Foundation Clinical Research Award in Lung Cancer
  • 2005
    Barbara Parisi Lung Cancer Research Grant, Joan’s Legacy Foundation
  • 2005
    Clinical Scientist Development Award, Doris Duke Charitable Foundation
  • 2007
    Hope Now Award for Lung Cancer Research, Joan’s Legacy Foundation 
  • 2009
    Stand Up to Cancer (SU2C) AACR Innovative Grant Award
  • 2009
    V Foundation Grant
  • 2011
    Inducted into American Society for Clinical Investigation
  • 2011
    Sidwell Friends School Distinguished Alumni Award
  • 2011
    Nashville’s Top Doctors List, Nashville Lifestyles Magazine
  • 2013
    Chinese American Medical Society Scientific Award
  • 2014
    Thomson Reuters List of the World’s Most Influential Scientific Minds – Clinical Medicine
  • 2014-2016
    Thomson Reuters Highly Cited Researcher List – Clinical Medicine
  • 2017
    Inducted into Association of American Physicians

Professional Associations

  • 1991
    American Association for the Advancement of Science, Member 
  • 1999
    American College of Physicians, Member 
  • 2000
    American Society of Clinical Oncology, Member 
  • 2003
    American Association for Cancer Research, Active Member 
  • 2006
    American College of Chest Physicians, Fellow 
  • 2006
    The Harvey Society
  • 2006
    International Association for the Study of Lung Cancer
  • 2011
    American Society for Clinical Investigation
  • 2017
    Association of American Physicians
  • 2020
    NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, Executive Committee member

Board Memberships in listed companies

  • -